Axiom Investors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-35,688	Closed	-$2.1M	–	139
2018 Q2	$2.1M	Hold	35,688	–	–	0.06%	125
2018 Q1	$1.63M	Buy	+35,688	New	+$1.63M	0.04%	129